Enliven Therapeutics, Inc. ($ELVN)
Filing Information
| Accession Number | 0001584759-26-000007 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 22, 2026 |
| Document Date | Jan 20, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
1,230
Total Value
$32,901.52
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jan 20, 2026 | Sale | 512 | $26.46 | $13,547.11 | 24,595 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jan 20, 2026 | Sale | 718 | $26.96 | $19,354.41 | 23,877 | Indirect | See footnote | View Details |